03/10/2024
11:15 PM | Evelo Biosciences (Filer)
| Form EFFECT | |
01/26/2024
4:26 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
4:27 PM | Evelo Biosciences (Filer)
| Form POS AM | |
01/26/2024
4:28 PM | Evelo Biosciences (Filer)
| Form S-8 POS | |
01/26/2024
4:29 PM | Evelo Biosciences (Filer)
| Form S-8 POS | |
01/26/2024
4:30 PM | Evelo Biosciences (Filer)
| Form 15-12G | |
12/27/2023
8:02 AM | Evelo Biosciences (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
|
12/12/2023
6:42 AM | Evelo Biosciences (Filer)
| Form DEF 14A | |
12/12/2023
6:43 AM | Evelo Biosciences (Filer)
| Form DEFA14A | |
12/11/2023
8:09 AM | Evelo Biosciences (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
12/04/2023
5:04 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
6:11 AM | Evelo Biosciences (Filer)
| Form PRE 14A | |
11/21/2023
5:44 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
8:02 AM | Evelo Biosciences (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2023
7:31 PM | Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:31 PM | Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:32 PM | Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:32 PM | Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
4:24 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
6:05 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
7:54 PM | Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
7:55 PM | Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
7:55 PM | Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
4:25 PM | Evelo Biosciences (Filer)
| Form 424B3 | |
08/21/2023
6:43 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
11:15 PM | Evelo Biosciences (Filer)
| Form EFFECT | |
08/14/2023
7:14 AM | Evelo Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:42 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:19 AM | Evelo Biosciences (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/09/2023
7:44 PM | Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:42 PM | Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:42 PM | Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:43 PM | Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
6:21 PM | Evelo Biosciences (Issuer)
Horizon Technology Finance Corp (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/21/2023
2:46 PM | Evelo Biosciences (Subject)
Horizon Technology Finance Corp (Filed by)
| Form SC 13G | |
07/21/2023
7:00 AM | Evelo Biosciences (Subject)
HarbourVest Partners L.P. (Filed by)
| Form SC 13G | |
07/20/2023
3:21 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
4:15 PM | AFEYAN NOUBAR (Reporting)
Evelo Biosciences (Issuer)
Flagship Pioneering Fund VII General Partner LLC (Reporting)
Flagship Pioneering Fund VII, L.P. (Reporting)
Flagship Pioneering Inc. (Reporting)
Flagship Ventures Fund IV General Partner LLC (Reporting)
Flagship Ventures Fund IV, L.P. (Reporting)
Nutritional Health LTP Fund General Partner LLC (Reporting)
Nutritional Health LTP Fund, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:03 PM | Evelo Biosciences (Issuer)
Moore Jeffrey R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/12/2023
3:05 PM | Evelo Biosciences (Issuer)
Moore Jeffrey R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:06 PM | Evelo Biosciences (Issuer)
Reynolds Alexander C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
07/12/2023
3:08 PM | Evelo Biosciences (Issuer)
Reynolds Alexander C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
6:55 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
9:20 AM | Evelo Biosciences (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
07/10/2023
6:36 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:06 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
4:10 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:54 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:09 PM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
7:21 AM | Evelo Biosciences (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
05/22/2023
5:33 AM | Evelo Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
3:43 PM | Evelo Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
8:31 PM | Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
8:31 PM | Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
8:31 PM | Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
8:32 PM | Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
